Novavax Inc (NVAX)
8.715
+0.04
(+0.40%)
USD |
NASDAQ |
Dec 20, 16:00
8.70
-0.02
(-0.17%)
After-Hours: 07:51
Novavax Free Cash Flow: -112.35M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Pfizer Inc | 8.227B |
| Moderna Inc | -3.956B |
| Inovio Pharmaceuticals Inc | -111.18M |
| Baxter International Inc | 391.00M |
| Halozyme Therapeutics Inc | 392.71M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -144.81M |
| Cash from Investing (Quarterly) | 31.91M |
| Cash from Financing (Quarterly) | -0.097M |
| Free Cash Flow Per Share (Quarterly) | -0.9174 |
| Free Cash Flow to Equity (Quarterly) | -147.24M |
| Free Cash Flow to Firm (Quarterly) | -142.63M |
| Free Cash Flow Yield | -8.74% |